The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality-adjusted life years (QALY) for inotuzumab ozogamicin vs standard of care for relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
 
Ilse van Oostrum
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Merck (Inst); Pfizer (Inst)
Research Funding - Amgen (Inst); Celgene (Inst); Merck (Inst); Pfizer (Inst)
 
Yun Su
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Bart Heeg
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Johnson & Johnson; Merck; Pfizer; Sanofi
Research Funding - Amgen; AstraZeneca; Celgene; Johnson & Johnson; Merck; Pfizer; Sanofi
 
Thomas Wilke
Honoraria - Bayer; Novo Nordisk
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); LEO Pharma (Inst); Merck (Inst); Novo Nordisk (Inst); Pharmerit (Inst)
 
Alexander Smith
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fausto Rodriguez Loberiza
Employment - Pfizer
Stock and Other Ownership Interests - Novartis; Pfizer